{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:44:45Z","timestamp":1789829085493,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374539"],"award-info":[{"award-number":["82374539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374539"],"award-info":[{"award-number":["82374539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project of Jiangsu Traditional Chinese Medicine Science and Technology Development Plan","award":["ZD202214"],"award-info":[{"award-number":["ZD202214"]}]},{"name":"Jiangsu Traditional Chinese Medicine Leading Talents Training Object Project","award":["SLJ0327"],"award-info":[{"award-number":["SLJ0327"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03937-5","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T11:25:03Z","timestamp":1753529103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Global, regional, and national burden and trends of prostate cancer in elderly from 1990 to 2021: results from global burden of disease 2021"],"prefix":"10.1186","volume":"23","author":[{"given":"Yinghong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"9","key":"3937_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41588-020-0642-1","volume":"52","author":"W Guo","year":"2020","unstructured":"Guo W, Li L, He J, et al. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat Genet. 2020;52(9):908\u201318.","journal-title":"Nat Genet"},{"key":"3937_CR2","unstructured":"Society AC. Facts & Figs. 2022. accessed on 28 May 2023."},{"issue":"3","key":"3937_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3937_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2012.10.002","volume":"63","author":"M Popiolek","year":"2013","unstructured":"Popiolek M, Rider JR, Andr\u00e9n O, et al. Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol. 2013;63(3):428\u201335.","journal-title":"Eur Urol"},{"issue":"1","key":"3937_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12957-025-03733-1","volume":"23","author":"F Chu","year":"2025","unstructured":"Chu F, Chen L, Guan Q, et al. Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040. World J Surg Oncol. 2025;23(1):98.","journal-title":"World J Surg Oncol"},{"issue":"15","key":"3937_CR6","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane JA, et al. Patient-Reported outcomes after monitoring, surgery, or radiotherapy for prostate Cancer. N Engl J Med. 2016;375(15):1425\u201337.","journal-title":"N Engl J Med"},{"issue":"4","key":"3937_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.annonc.2020.02.002","volume":"31","author":"R Ge","year":"2020","unstructured":"Ge R, Wang Z, Montironi R, et al. Epigenetic modulations and lineage plasticity in advanced prostate cancer. Ann Oncol. 2020;31(4):470\u20139.","journal-title":"Ann Oncol"},{"issue":"1","key":"3937_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jfcm.jfcm_211_24","volume":"32","author":"NSA Mohamed","year":"2025","unstructured":"Mohamed NSA, Asfari JMO, Sambawa SMA, et al. Awareness of prostate cancer and its screening tests in men in the middle east: A systematic review and meta-analysis. J Family Community Med. 2025;32(1):1\u201315.","journal-title":"J Family Community Med"},{"issue":"15","key":"3937_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJMcp2209151","volume":"388","author":"PF Pinsky","year":"2023","unstructured":"Pinsky PF, Parnes H. Screening for prostate Cancer. N Engl J Med. 2023;388(15):1405\u201314.","journal-title":"N Engl J Med"},{"issue":"6","key":"3937_CR10","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3937_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0094-0143(21)01800-0","volume":"16","author":"PT Scardino","year":"1989","unstructured":"Scardino PT. Early detection of prostate cancer. Urol Clin North Am. 1989;16(4):635\u201355.","journal-title":"Urol Clin North Am"},{"issue":"2","key":"3937_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13167-019-00169-y","volume":"10","author":"R Sharma","year":"2019","unstructured":"Sharma R. The burden of prostate cancer is associated with human development index: evidence from 87 countries, 1990\u20132016. Epma J. 2019;10(2):137\u201352.","journal-title":"Epma J"},{"issue":"3","key":"3937_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41416-020-0859-x","volume":"123","author":"EN Butler","year":"2020","unstructured":"Butler EN, Kelly SP, Coupland VH, et al. Fatal prostate cancer incidence trends in the united States and England by race, stage, and treatment. Br J Cancer. 2020;123(3):487\u201394.","journal-title":"Br J Cancer"},{"key":"3937_CR14","doi-asserted-by":"publisher","unstructured":"Satapathy P, Gaidhane S, Sanghvi G et al. Prostate cancer in central and Eastern europe: a comprehensive regional analysis of burden, trends, and future projections based on the global burden of disease study (1990\u20132021). Expert Rev Anticancer Ther. 2025;25(5);571\u20137. https:\/\/doi.org\/10.1080\/14737140.2025.2483853","DOI":"10.1080\/14737140.2025.2483853"},{"issue":"1","key":"3937_CR15","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/s41598-024-83840-3","volume":"15","author":"S Safiri","year":"2025","unstructured":"Safiri S, Shamekh A, Hassanzadeh K, et al. The burden of prostate cancer in the North Africa and middle East region from 1990 to 2021. Sci Rep. 2025;15(1):1853.","journal-title":"Sci Rep"},{"issue":"3","key":"3937_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/iju.15641","volume":"32","author":"V Kumar","year":"2025","unstructured":"Kumar V, Jena D, Zahiruddin QS, et al. Prostate cancer burden in South asia: A systematic analysis of global burden of disease data (1990\u20132021). Int J Urol. 2025;32(3):277\u201384.","journal-title":"Int J Urol"},{"issue":"10440","key":"3937_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Global incidence","year":"2024","unstructured":"Global incidence. prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"key":"3937_CR18","doi-asserted-by":"publisher","first-page":"1553129","DOI":"10.3389\/fmicb.2025.1553129","volume":"16","author":"S Yang","year":"2025","unstructured":"Yang S, Zhong L, Huang L, et al. Global burden and trends of viral hepatitis among women of childbearing age from 1990 to 2021. Front Microbiol. 2025;16:1553129.","journal-title":"Front Microbiol"},{"key":"3937_CR19","doi-asserted-by":"publisher","first-page":"102613","DOI":"10.1016\/j.arr.2024.102613","volume":"104","author":"Q Liu","year":"2025","unstructured":"Liu Q, Wang H, Chen Z, et al. Global, regional, and National epidemiology of nasopharyngeal carcinoma in middle-aged and elderly patients from 1990 to 2021. Ageing Res Rev. 2025;104:102613.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"3937_CR20","doi-asserted-by":"publisher","first-page":"103708","DOI":"10.1016\/j.autrev.2024.103708","volume":"24","author":"L Chen","year":"2025","unstructured":"Chen L, Cheng S, Zhang B, et al. Burden of inflammatory bowel disease among elderly, 1990\u20132019: A systematic analysis based on the global burden of disease study 2019. Autoimmun Rev. 2025;24(2):103708.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3937_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-024-01798-z","volume":"25","author":"J Cen","year":"2024","unstructured":"Cen J, Wang Q, Cheng L, et al. Global, regional, and National burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the global burden of disease study 2021. J Headache Pain. 2024;25(1):96.","journal-title":"J Headache Pain"},{"issue":"3\u20134","key":"3937_CR22","first-page":"171","volume":"50","author":"P Das Gupta","year":"1994","unstructured":"Das Gupta P. Standardization and decomposition of rates from cross-classified data. Genus. 1994;50(3\u20134):171\u201396.","journal-title":"Genus"},{"issue":"2","key":"3937_CR23","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"Estimation of the global prevalence of dementia","year":"2022","unstructured":"Estimation of the global prevalence of dementia. In 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"1","key":"3937_CR24","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12885-024-12480-7","volume":"24","author":"G Huang","year":"2024","unstructured":"Huang G, Wang Y, Qin B, et al. Global, regional and National burdens of nasopharynx cancer in the adolescents and young adults from 1990 to 2019 and its predictions. BMC Cancer. 2024;24(1):720.","journal-title":"BMC Cancer"},{"issue":"5","key":"3937_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.canep.2013.07.002","volume":"37","author":"Z Xu","year":"2013","unstructured":"Xu Z, Hertzberg VS. Bayesian area-age-period-cohort model with carcinogenesis age effects in estimating cancer mortality. Cancer Epidemiol. 2013;37(5):593\u2013600.","journal-title":"Cancer Epidemiol"},{"key":"3937_CR26","doi-asserted-by":"publisher","first-page":"k3519","DOI":"10.1136\/bmj.k3519","volume":"362","author":"D Ilic","year":"2018","unstructured":"Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519.","journal-title":"BMJ"},{"key":"3937_CR27","doi-asserted-by":"publisher","first-page":"1544882","DOI":"10.3389\/fimmu.2025.1544882","volume":"16","author":"J Che","year":"2025","unstructured":"Che J, Liu Y, Liu Y, et al. The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise. Front Immunol. 2025;16:1544882.","journal-title":"Front Immunol"},{"key":"3937_CR28","doi-asserted-by":"publisher","unstructured":"Gharbieh S, Mullin J, Jaffer A, et al. Epidemiology, diagnosis and treatment of anterior prostate cancer. Nat Rev Urol. 2025;22(7):439\u201346. https:\/\/doi.org\/10.1038\/s41585-024-00992-7","DOI":"10.1038\/s41585-024-00992-7"},{"issue":"13","key":"3937_CR29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320\u20138.","journal-title":"N Engl J Med"},{"issue":"703","key":"3937_CR30","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.3399\/bjgp20X713957","volume":"71","author":"AK Clift","year":"2021","unstructured":"Clift AK, Coupland CA, Hippisley-Cox J. Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in england, 1998\u20132017. Br J Gen Pract. 2021;71(703):e157\u201365.","journal-title":"Br J Gen Pract"},{"issue":"6suppl","key":"3937_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1200\/JCO.2021.39.6_suppl.228","volume":"39","author":"V Sharma","year":"2021","unstructured":"Sharma V, Venkataramana A, Comulada WS, et al. Association of reductions in PSA screening across States with increased metastatic prostate cancer in the united States. J Clin Oncol. 2021;39(6suppl):228.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3937_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","volume":"19","author":"H Van Poppel","year":"2022","unstructured":"Van Poppel H, Albreht T, Basu P, et al. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat Rev Urol. 2022;19(9):562\u201372.","journal-title":"Nat Rev Urol"},{"key":"3937_CR33","doi-asserted-by":"crossref","unstructured":"Dushimova Z, Iztleuov Y, Chingayeva G et al. Overdiagnosis and overtreatment in prostate Cancer. Diseases. 2025;13(6).","DOI":"10.3390\/diseases13060167"},{"issue":"1","key":"3937_CR34","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1038\/s41598-025-88392-8","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang P, Jia Z, et al. Global burden and risk factors of male cancers from 1990 to 2021, with forecasts to 2040. Sci Rep. 2025;15(1):5123.","journal-title":"Sci Rep"},{"issue":"5","key":"3937_CR35","first-page":"760","volume":"23","author":"FC Militaru","year":"2023","unstructured":"Militaru FC, Militaru V, Crisan N, et al. Molecular basis and therapeutic targets in prostate cancer: A comprehensive review. Biomol Biomed. 2023;23(5):760\u201371.","journal-title":"Biomol Biomed"},{"issue":"4","key":"3937_CR36","doi-asserted-by":"publisher","first-page":"155798832094546","DOI":"10.1177\/1557988320945465","volume":"14","author":"N Malika","year":"2020","unstructured":"Malika N, Ogundimu O, Roberts L, et al. African immigrant health: prostate Cancer attitudes, perceptions, and barriers. Am J Mens Health. 2020;14(4):1557988320945465.","journal-title":"Am J Mens Health"},{"key":"3937_CR37","doi-asserted-by":"publisher","first-page":"112461","DOI":"10.1016\/j.socscimed.2019.112461","volume":"237","author":"E Mendenhall","year":"2019","unstructured":"Mendenhall E, Bosire EN, Kim AW, et al. Cancer, chemotherapy, and HIV: living with cancer amidst comorbidity in a South African Township. Soc Sci Med. 2019;237:112461.","journal-title":"Soc Sci Med"},{"issue":"10","key":"3937_CR38","doi-asserted-by":"publisher","first-page":"e0276050","DOI":"10.1371\/journal.pone.0276050","volume":"17","author":"W Mapanga","year":"2022","unstructured":"Mapanga W, Norris SA, Craig A, et al. Prevalence of Multimorbidity in men of African descent with and without prostate cancer in soweto, South Africa. PLoS ONE. 2022;17(10):e0276050.","journal-title":"PLoS ONE"},{"issue":"2","key":"3937_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al. 2022 update on prostate Cancer epidemiology and risk Factors-A systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"5","key":"3937_CR40","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.21037\/tau-2025-103","volume":"14","author":"X Lin","year":"2025","unstructured":"Lin X, Zhi Y. Global epidemiological trends in prostate cancer burden: a comprehensive analysis from global burden of disease study 2021. Transl Androl Urol. 2025;14(5):1238\u201352.","journal-title":"Transl Androl Urol"},{"issue":"3","key":"3937_CR41","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1057\/s41271-024-00502-4","volume":"45","author":"LA Georgiou","year":"2024","unstructured":"Georgiou LA, Scarbrough BE. PSA screening for prostate cancer in the united states: 30 years of controversy. J Public Health Policy. 2024;45(3):552\u201361.","journal-title":"J Public Health Policy"},{"key":"3937_CR42","doi-asserted-by":"publisher","first-page":"102093","DOI":"10.1016\/j.canep.2021.102093","volume":"77","author":"T Pathirana","year":"2022","unstructured":"Pathirana T, Sequeira R, Del Mar C, et al. Trends in prostate specific antigen (PSA) testing and prostate cancer incidence and mortality in australia: A critical analysis. Cancer Epidemiol. 2022;77:102093.","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"3937_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/JU.0000000000000617","volume":"203","author":"MA Bjurlin","year":"2020","unstructured":"Bjurlin MA, Carroll PR, Eggener S, et al. Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate Cancer. J Urol. 2020;203(4):706\u201312.","journal-title":"J Urol"},{"issue":"1","key":"3937_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, et al. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77(1):38\u201352.","journal-title":"Eur Urol"},{"key":"3937_CR45","doi-asserted-by":"publisher","first-page":"811044","DOI":"10.3389\/fpubh.2022.811044","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, Lu B, He M, et al. Prostate Cancer incidence and mortality: global status and Temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044.","journal-title":"Front Public Health"},{"issue":"3","key":"3937_CR46","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/S2542-5196(21)00352-1","volume":"6","author":"V Miller","year":"2022","unstructured":"Miller V, Reedy J, Cudhea F, et al. Global, regional, and National consumption of animal-source foods between 1990 and 2018: findings from the global dietary database. Lancet Planet Health. 2022;6(3):e243\u201356.","journal-title":"Lancet Planet Health"},{"issue":"8","key":"3937_CR47","first-page":"2229","volume":"19","author":"W You","year":"2018","unstructured":"You W, Henneberg M. Prostate Cancer incidence is correlated to total meat Intake \u2013 a Cross-National Ecologic analysis of 172 countries. Asian Pac J Cancer Prev. 2018;19(8):2229\u201339.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"3937_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ehb.2007.08.002","volume":"5","author":"C Knai","year":"2007","unstructured":"Knai C, Suhrcke M, Lobstein T. Obesity in Eastern europe: an overview of its health and economic implications. Econ Hum Biol. 2007;5(3):392\u2013408.","journal-title":"Econ Hum Biol"},{"issue":"8","key":"3937_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1467-789X.2012.00999.x","volume":"13","author":"L Webber","year":"2012","unstructured":"Webber L, Kilpi F, Marsh T, et al. Modelling obesity trends and related diseases in Eastern Europe. Obes Rev. 2012;13(8):744\u201351.","journal-title":"Obes Rev"},{"issue":"11","key":"3937_CR50","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1158\/1055-9965.EPI-08-0609","volume":"17","author":"T Pischon","year":"2008","unstructured":"Pischon T, Boeing H, Weikert S, et al. Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3252\u201361.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"3937_CR51","doi-asserted-by":"publisher","first-page":"e201839","DOI":"10.1001\/jamanetworkopen.2020.1839","volume":"3","author":"SA Fletcher","year":"2020","unstructured":"Fletcher SA, Marchese M, Cole AP, et al. Geographic distribution of Racial differences in prostate Cancer mortality. JAMA Netw Open. 2020;3(3):e201839.","journal-title":"JAMA Netw Open"},{"key":"3937_CR52","doi-asserted-by":"crossref","unstructured":"Tan SH, Petrovics G, Srivastava S. Prostate Cancer genomics: recent advances and the prevailing underrepresentation from Racial and ethnic minorities. Int J Mol Sci. 2018;19(4).","DOI":"10.3390\/ijms19041255"},{"issue":"3","key":"3937_CR53","first-page":"144","volume":"23","author":"JW Shevach","year":"2025","unstructured":"Shevach JW, Cooney KA. Genetics of prostate cancer. Clin Adv Hematol Oncol. 2025;23(3):144\u201352.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"2","key":"3937_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajur.2016.08.010","volume":"4","author":"K Zhang","year":"2017","unstructured":"Zhang K, Bangma CH, Roobol MJ. Prostate cancer screening in Europe and Asia. Asian J Urol. 2017;4(2):86\u201395.","journal-title":"Asian J Urol"},{"issue":"10","key":"3937_CR55","doi-asserted-by":"publisher","first-page":"e2440381","DOI":"10.1001\/jamanetworkopen.2024.40381","volume":"7","author":"M Li","year":"2024","unstructured":"Li M, Hu M, Jiang L, et al. Trends in Cancer incidence and potential associated factors in China. JAMA Netw Open. 2024;7(10):e2440381.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"3937_CR56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345\u201359.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3937_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41585-022-00686-y","volume":"20","author":"R Kumar","year":"2023","unstructured":"Kumar R, Sena LA, Denmeade SR, et al. The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications. Nat Rev Urol. 2023;20(5):265\u201378.","journal-title":"Nat Rev Urol"},{"key":"3937_CR58","unstructured":"Nations U. World Population Prospects. 2015."},{"issue":"3","key":"3937_CR59","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/S2468-2667(19)30019-2","volume":"4","author":"AY Chang","year":"2019","unstructured":"Chang AY, Skirbekk VF, Tyrovolas S, et al. Measuring population ageing: an analysis of the global burden of disease study 2017. Lancet Public Health. 2019;4(3):e159\u201367.","journal-title":"Lancet Public Health"},{"issue":"21","key":"3937_CR60","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1039\/D4FO03859B","volume":"15","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Xu J, Zhao Y, et al. Relationships of dietary habits with prostate cancer risk: results from Mendelian randomization analyses and the National health and nutrition examination survey. Food Funct. 2024;15(21):10823\u201337.","journal-title":"Food Funct"},{"issue":"2","key":"3937_CR61","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/aje\/kwae184","volume":"194","author":"F Guo","year":"2025","unstructured":"Guo F, McGee EE, Chiu YH, et al. Evaluating recommendation-based dietary and physical activity strategies for prostate cancer prevention: a target trial emulation in the health professionals Follow-up study. Am J Epidemiol. 2025;194(2):449\u201359.","journal-title":"Am J Epidemiol"},{"key":"3937_CR62","doi-asserted-by":"crossref","unstructured":"Lozano-Lorca M, Mu\u00f1oz-Bravo C, Barrios-Rodr\u00edguez R et al. Dietary and smoking acrylamide and prostate Cancer risk: CAPLIFE study. Nutrients. 2024;16(6).","DOI":"10.3390\/nu16060836"},{"issue":"9","key":"3937_CR63","first-page":"1259","volume":"35","author":"ET Ellis","year":"2024","unstructured":"Ellis ET, Fairman BJ, Stahr SD, et al. Cigarette smoking and prostate cancer aggressiveness among African and European American men. Cancer Causes Control. 2024;35(9):1259\u201369.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"3937_CR64","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.euo.2019.05.004","volume":"2","author":"S Woo","year":"2019","unstructured":"Woo S, Suh CH, Eastham JA, et al. Comparison of magnetic resonance Imaging-stratified clinical pathways and systematic transrectal Ultrasound-guided biopsy pathway for the detection of clinically significant prostate cancer: A systematic review and Meta-analysis of randomized controlled trials. Eur Urol Oncol. 2019;2(6):605\u201316.","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"3937_CR65","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.juro.2018.01.070","volume":"199","author":"A Vickers","year":"2018","unstructured":"Vickers A, Vertosick EA, Sjoberg DD, et al. Value of intact prostate specific antigen and human Kallikrein 2 in the 4 Kallikrein predictive model: an individual patient data Meta-Analysis. J Urol. 2018;199(6):1470\u20134.","journal-title":"J Urol"},{"issue":"3","key":"3937_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40291-022-00584-4","volume":"26","author":"M Campistol","year":"2022","unstructured":"Campistol M, Morote J, Regis L, Proclarix, et al. A new biomarker for the diagnosis of clinically significant prostate cancer: A systematic review. Mol Diagn Ther. 2022;26(3):273\u201381.","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"3937_CR67","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.eururo.2017.12.028","volume":"74","author":"P Str\u00f6m","year":"2018","unstructured":"Str\u00f6m P, Nordstr\u00f6m T, Aly M, et al. The Stockholm-3 model for prostate Cancer detection: algorithm update, biomarker contribution, and reflex test potential. Eur Urol. 2018;74(2):204\u201310.","journal-title":"Eur Urol"},{"issue":"10071","key":"3937_CR68","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815\u201322.","journal-title":"Lancet"},{"issue":"11","key":"3937_CR69","doi-asserted-by":"publisher","first-page":"13151","DOI":"10.3390\/cimb46110784","volume":"46","author":"A Zhang","year":"2024","unstructured":"Zhang A, Deng W, Shang H, et al. miR-5100 overexpression inhibits prostate Cancer progression by inducing cell cycle arrest and targeting E2F7. Curr Issues Mol Biol. 2024;46(11):13151\u201364.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"3937_CR70","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13062-024-00494-x","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ji B, Zhang L, et al. Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches. Biol Direct. 2024;19(1):50.","journal-title":"Biol Direct"},{"issue":"3","key":"3937_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.7326\/0003-4819-158-3-201302050-00003","volume":"158","author":"R Gulati","year":"2013","unstructured":"Gulati R, Gore JL, Etzioni R. Comparative effectiveness of alternative prostate-specific antigen\u2013based prostate cancer screening strategies: model estimates of potential benefits and harms. Ann Intern Med. 2013;158(3):145\u201353.","journal-title":"Ann Intern Med"},{"issue":"4suppl","key":"3937_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO.2024.42.4_suppl.25","volume":"42","author":"C Jani","year":"2024","unstructured":"Jani C, Dudipala H, Tran E, et al. Evolving trends in prostate cancer: disparities across income levels and global regions (1990\u20132019). J Clin Oncol. 2024;42(4suppl):25.","journal-title":"J Clin Oncol"},{"key":"3937_CR73","doi-asserted-by":"publisher","first-page":"2463048","DOI":"10.1155\/2019\/2463048","volume":"2019","author":"FC Bugoye","year":"2019","unstructured":"Bugoye FC, Leyna GH, Moen K, et al. Knowledge, perceived risk and utilization of prostate Cancer screening services among men in Dar Es salaam, Tanzania. Prostate Cancer. 2019;2019:2463048.","journal-title":"Prostate Cancer"},{"key":"3937_CR74","doi-asserted-by":"publisher","first-page":"110759","DOI":"10.1016\/j.clinbiochem.2024.110759","volume":"127\u2013128","author":"L Agnello","year":"2024","unstructured":"Agnello L, Vidali M, Salvaggio G, et al. Prostate health index (PHI) as a triage tool for reducing unnecessary magnetic resonance imaging (MRI) in patients at risk of prostate cancer. Clin Biochem. 2024;127\u2013128:110759.","journal-title":"Clin Biochem"},{"issue":"19","key":"3937_CR75","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1002\/cam4.3387","volume":"9","author":"A Jatho","year":"2020","unstructured":"Jatho A, Mugisha NM, Kafeero J, et al. Mobile cancer prevention and early detection outreach in uganda: partnering with communities toward bridging the cancer health disparities through asset-based community development model. Cancer Med. 2020;9(19):7317\u201329.","journal-title":"Cancer Med"},{"key":"3937_CR76","doi-asserted-by":"crossref","unstructured":"Vakili S, Beheshti I, Barzegar Behrooz A et al. Transforming prostate Cancer care: innovations in diagnosis, treatment, and future directions. Int J Mol Sci. 2025;26(11).","DOI":"10.3390\/ijms26115386"},{"key":"3937_CR77","doi-asserted-by":"publisher","unstructured":"Ferrando MR, Proietti E, Demontis M, Montecucco F, Pisciotta L. Sustainable development goals: a call for future internal medicine. Intern Emerg Med. 2025. https:\/\/doi.org\/10.1007\/s11739-025-03941-3","DOI":"10.1007\/s11739-025-03941-3"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03937-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03937-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03937-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:43:46Z","timestamp":1757306626000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03937-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3937"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03937-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A secondary evaluation of the publicly accessible GBD Study dataset was conducted, without primary data collection. Thus, no ethics approval was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}